T. Rowe Price Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,288
| Closed | -$2.06M | – | 3086 |
|
|
2024
Q4 | $2.06M | Sell |
40,288
-130,154
| -76% | -$6.65M | ﹤0.01% | 1629 |
|
|
2024
Q3 | $7.03M | Sell |
170,442
-133,591
| -44% | -$5.51M | ﹤0.01% | 1209 |
|
|
2024
Q2 | $14.6M | Sell |
304,033
-69,314
| -19% | -$3.34M | ﹤0.01% | 1033 |
|
|
2024
Q1 | $17.9M | Buy |
373,347
+2,003
| +0.5% | +$96.1K | ﹤0.01% | 996 |
|
|
2023
Q4 | $24.1M | Sell |
371,344
-878,550
| -70% | -$57M | ﹤0.01% | 910 |
|
|
2023
Q3 | $81.7M | Sell |
1,249,894
-109,443
| -8% | -$7.16M | 0.01% | 548 |
|
|
2023
Q2 | $79M | Sell |
1,359,337
-504,479
| -27% | -$29.3M | 0.01% | 576 |
|
|
2023
Q1 | $115M | Buy |
1,863,816
+1,060,839
| +132% | +$65.5M | 0.02% | 486 |
|
|
2022
Q4 | $51M | Buy |
802,977
+139,929
| +21% | +$8.89M | 0.01% | 654 |
|
|
2022
Q3 | $48.2M | Sell |
663,048
-1,303,254
| -66% | -$94.7M | 0.01% | 656 |
|
|
2022
Q2 | $134M | Buy |
1,966,302
+356,309
| +22% | +$24.2M | 0.02% | 582 |
|
|
2022
Q1 | $146M | Buy |
1,609,993
+490,718
| +44% | +$44.5M | 0.01% | 625 |
|
|
2021
Q4 | $102M | Buy |
1,119,275
+241,112
| +27% | +$22M | 0.01% | 762 |
|
|
2021
Q3 | $71.2M | Buy |
878,163
+575,397
| +190% | +$46.7M | 0.01% | 889 |
|
|
2021
Q2 | $28.2M | Sell |
302,766
-269,128
| -47% | -$25.1M | ﹤0.01% | 1215 |
|
|
2021
Q1 | $61.2M | Sell |
571,894
-14,562
| -2% | -$1.56M | 0.01% | 928 |
|
|
2020
Q4 | $51.2M | Sell |
586,456
-2,403
| -0.4% | -$210K | 0.01% | 954 |
|
|
2020
Q3 | $40.6M | Sell |
588,859
-74,875
| -11% | -$5.17M | ﹤0.01% | 939 |
|
|
2020
Q2 | $32.2M | Buy |
+663,734
| New | +$32.2M | ﹤0.01% | 992 |
|